Tyvaso approval date?

When was Tyvaso (treprostinil) first approved?

Tyvaso (treprostinil) was approved by the FDA on September 19, 2009.1

Has the approval date changed with later versions or formulations?

The FDA tracks approvals by specific products/applications. Tyvaso’s original FDA approval date is still September 19, 2009; later labeling updates or alternate formulations (if applicable) would have their own FDA approval dates rather than replacing the original one.1

What is Tyvaso used for?

Tyvaso (treprostinil) is used to treat pulmonary arterial hypertension (PAH) and is administered via inhalation.1

Source